Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10660896 Transient protection of normal cells during chemotherapy

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10660896
Edits on 10 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 May, 2023
Edits on 22 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Infobox
Patent Citations
‌
US Patent 10189851 CDK inhibitors
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
‌
US Patent 10189850 CDK inhibitors
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
‌
US Patent 10189851 CDK inhibitors
0
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 22 Jun, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11364222 Combination therapy for treatment of cancer
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10660896
Edits on 3 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 3 Feb, 2022
Edits made to:
Infobox (+12 properties)
‌

 US Patent 10660896 Transient protection of normal cells during chemotherapy

Infobox
Is a
Patent
Patent
Patent applicant
G1 Therapeutics
G1 Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10660896
Date of patent
May 26, 2020
Patent application number
15943278
Date Filed
April 2, 2018
Patent citations
‌
US Patent 10085992 Transient protection of normal cells during chemotherapy
‌
US Patent 10189849 CDK inhibitors
‌
US Patent 10189850 CDK inhibitors
‌
US Patent 10189851 CDK inhibitors
Patent primary examiner
‌
My-Chau T. Tran

Find more entities like US Patent 10660896 Transient protection of normal cells during chemotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.